First case of ivermectin-induced severe hepatitis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 8, 2006, Pages 795-797

  Veit, Olivia ^a   Beck, Bernhard ^a   Steuerwald, Michael ^b   Hatz, Christoph ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Drug induced hepatitis; Ivermectin; Liver disease; Loa loa; Loiasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBENDAZOLE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; IVERMECTIN;

ABDOMINAL PAIN; ADULT; APOPTOSIS; ARTICLE; CAMEROON; CASE REPORT; DISEASE SEVERITY; EOSINOPHILIA; FEMALE; FILARIASIS; HEPATITIS; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LEUKOCYTE; LIVER BIOPSY; LIVER DISEASE; LIVER NECROSIS; LOA LOA; MICROFILARIASIS; SINGLE DRUG DOSE;

ADULT; ANIMALS; ANTIPARASITIC AGENTS; CAMEROON; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATITIS, TOXIC; HUMANS; IVERMECTIN; LOA; LOIASIS; MICROFILARIA;

LOA LOA;

EID: 33744981841     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.02.003     Document Type: Article

References (11)

1. Biour M., Ben Salem C., Chazouilleres O., Grange J.D., Serfaty L., and Poupon R. Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs. Gastroenterol. Clin. Biol. 28 (2004) 720-759
2. Boussinesq M., Gardon J., Gardon-Wendel N., Kamgno J., Ngoumou P., and Chippaux J.P. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am. J. Trop. Med. Hyg. 58 (1998) 461-469
3. Carme B., Boulesteix J., Boutes H., and Puruehnce M.F. Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. Am. J. Trop. Med. Hyg. 44 (1991) 684-690
4. Ducorps M., Gardon-Wendel N., Ranque S., Ndong W., Boussinesq M., Gardon J., Schneider D., and Chippaux J.P. Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin. Bull. Soc. Pathol. Exot. 88 (1995) 105-112
5. Gardon J., Gardon-Wendel N., Demanga-Ngangue, Kamgno J., Chippaux J.P., and Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350 (1997) 18-22
6. Guzzo C.A., Furtek C.I., Porras A.G., Chen C., Tipping R., Clineschmidt C.M., Sciberras D.G., Hsieh J.Y., and Lasseter K.C. Safety, tolerability and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J. Clin. Pharmacol. 42 (2002) 1122-1133
7. Horton R.J. Chemotherapy of Echinococcus infection in man with albendazole. Trans. R. Soc. Trop. Med. Hyg. 83 (1989) 97-102
8. Kombila M., Duong T.H., Ferrer A., Perret J.L., Marion M.C., Nguiri C., Gaxotte P., Manfoumbi M., and Richard-Lenoble D. Short- and long-term action of multiple doses of ivermectin on loiasis microfilaremia. Am. J. Trop. Med. Hyg. 58 (1998) 458-460
9. Morris D.L., and Smith P.G. Albendazole in hydatid disease-hepatocellular toxicity. Trans. R. Soc. Trop. Med. Hyg. 81 (1987) 343-344
10. Toure F.S., Mavoungou E., Kassambara L., Williams T., Wahl G., Millet P., and Egwang T.G. Human occult loiasis: field evaluation of a nested polymerase chain reaction. Trop. Med. Int. Health 6 (1998) 505-511
11. Zaha O., Hirata T., Kinjo F., Saito A., and Fukuhara H. Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart. J. Infect. Chemother. 8 (2002) 94-98